I want to become CM of Karnataka, says actor-cum-politician Ambareesh

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Kalaburagi, Mar 11: A suspected coronavirus patient who had returned to Kalaburagi from Saudi Arabia on February 29 passed away today in hospital.

It is said he was admitted to the hospital on March 5 after he showed flu symptoms. But, the family members of the patient had shifted him to Hyderabad from GIMS on Tuesday against the advice of the doctors.

However, the district administration and District Health Officer (DHO) M A Jabbar are waiting for the final report of throat swab of the patient sent for lab test.

The DHO has directed Taluk Health Officer Sharanabasappa Kyatanal to supervise until the final rites of the suspect person were performed.

Kalaburagi Deputy Commissioner B Sharat said the patient died on Tuesday night on his way back to Kalaburagi after the doctor stated that chances of his survival was bleak. "It is still a suspected coronavirus case. We are waiting for the report," he said.

Sharat said he developed severe respiratory problem coupled with cough, cold and fever. "As he was 76-year-old, he failed to respond to the treatment. It is yet to be confirmed if the cause of death was coronavirus," he said.

Bengaluru, May 16: The Karnataka government is expected to take a call on Monday on holding the Secondary Level School Certificate (SSLC) or class 10 examination, which were postponed due to COVID-19 lockdown.

Minister for Primary and Secondary Education S Suresh Kumar said there was a possibility that the state government may come out with a timetable on Monday. "We are holding a meeting regarding the SSLC examination," he told reporters here.

He also said there would be discussions on how to conduct the exams and precautionary measures to be taken in view of COVID-19.

"We have to make arrangements for masks, sanitisers and thermal scanners. We will set up a thermal scanner for a health check-up. We have to make separate seating arrangements for those having health issues. All these issues will be discussed on Monday," Kumar said.

The SSLC exams were supposed to commence from May 27 but due to the lockdown, it was postponed for an indefinite period.